Shares of Comfort Systems USA Inc (NYSE:FIX) rose sharply in pre-market trading after the company reported better-than-expected fourth-quarter financial results and raised its quarterly dividend.

Comfort Systems reported quarterly earnings of $9.37 per share which beat the analyst consensus estimate of $6.75 per share. The company reported quarterly sales of $2.646 billion which beat the analyst consensus estimate of $2.337 billion.

Comfort Systems shares jumped 4.6% to $1,436.25 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

• AIOS Tech Inc (NASDAQ:AIOS) gained 44.2% to $0.65 in pre-market trading after adding 3% on Thursday.
• Mangoceuticals Inc (NASDAQ:MGRX) gained 28.7% to $0.46 in pre-market trading after the company announced initial success for its newly launched all-inclusive injectable Testosterone Replacement Therapy treatment program.
• Opendoor Technologies Inc (NASDAQ:OPEN) gained 14.5% to $5.33 in pre-market trading after the company reported better-than-expected quarterly financial results.
• Namib Minerals (NASDAQ:NAMM) gained 13.8% to $4.12 in pre-market trading. Namib Minerals regained Nasdaq listing compliance.
• Modular Medical Inc (NASDAQ:MODD) gained 13.7% to $0.58 in pre-market trading after adding around 13% on Thursday.
• Healthy Choice Wellness Corp (NYSE:HCWC) gained 12.8% to $0.30 in pre-market trading.
• Moolec Science SA (NASDAQ:MLEC) rose 11.1% to $19.00 in pre-market trading after gaining 19% on Thursday. Moolec Science recently announced results from the crushing process of its U.S. GLASO1 safflower platform.
• Rackspace Technology, Inc. (NASDAQ:RXT) rose 9.4% to $1.34 in pre-market trading after falling over 10% on Thursday.
• AXT Inc (NASDAQ:AXTI) gained 8.4% to $25.80 in pre-market trading following fourth-quarter results.

Losers

• Twin Vee Powercats Co (NASDAQ:VEEE) dipped 50.9% to $0.46 in pre-market trading after the company announced pricing of public offering.
• Grail Inc (NASDAQ:GRAL) fell 47.7% to $52.99 in pre-market trading after the company reported worse-than-expected quarterly sales results. Topline results for HS-Galleri Trial did not meet its primary endpoint of statistically significant Stage III-IV reduction.
• Knorex Ltd (NYSE:KNRX) fell 25.8% to $1.77 in pre-market trading. KNOREX shares jumped around 167% on Thursday after the company announced the launch of its agentic AI-ready Ads API to power cross-channel advertising automation.
• X3 Holdings Co Ltd (NASDAQ:XTKG) fell 18% to $0.084 in pre-market trading. The company recently announced it formally filed its appeal with the Nasdaq Hearings Panel in response to the delisting determination letter from the Nasdaq.
• Dermata Therapeutics Inc (NASDAQ:DRMA) shares dipped 17.7% to $1.59 in pre-market trading after gaining over 50% on Thursday.
• Interactive Strength Inc (NASDAQ:TRNR) dipped 16.8% to $0.36 in pre-market trading. Interactive Strength shares gained around 5% on Thursday after the company announced it acquired Ergatta.
• Inseego Corp (NASDAQ:INSG) fell 16.1% to $8.86 in pre-market trading after the company reported fourth-quarter financial results and issued first-quarter sales guidance below estimates.
• C3is Inc (NASDAQ:CISS) declined 15.2% to $1.86 in pre-market trading. C3is shares gained 31% on Thursday after the company reported a year-over-year increase in quarterly financial results.
• Rubico Inc (NASDAQ:RUBI) tumbled 15.1% to $1.52 in pre-market trading after dipping 20% on Thursday.
• Akamai Technologies Inc (NASDAQ:AKAM) fell 8.8% to $99.94 in pre-market trading after the company reported fourth-quarter financial results and issued FY26 adjusted EPS guidance below estimates. Also, the company issued first-quarter adjusted EPS guidance below estimates.

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.